Lessons from comprehensive immune profiling and innovative data analysis in preclinical and patient-based studies”. By integrating cutting-edge immune phenotyping techniques connected to innovative data science approaches, Guillem was able to unveil novel and unexpected immune cell mechanisms in preclinical and clinical applications of AIT. The results from his PhD project will help to further develop better approaches and biomarkers for AIT and provide profound knowledge for immune regulatory therapies.
|25 Jun 2021
|Published - 25 Jun 2021